Veliparib dihydrochloride

CAS No. 912445-05-7

Veliparib dihydrochloride( ABT-888 dihydrochloride | ABT888 dihydrochloride | ABT 888 dihydrochloride )

Catalog No. M16549 CAS No. 912445-05-7

Veliparib (ABT-888) is a potent, BBB penetrant, and orally active PARP inhibitor with IC50 of 5.2 and 2.9 nM for PARP-1 and PARP-2, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 60 In Stock
25MG 107 In Stock
50MG 177 In Stock
100MG 285 In Stock
200MG 465 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Veliparib dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Veliparib (ABT-888) is a potent, BBB penetrant, and orally active PARP inhibitor with IC50 of 5.2 and 2.9 nM for PARP-1 and PARP-2, respectively.
  • Description
    Veliparib (ABT-888) is a potent, BBB penetrant, and orally active PARP inhibitor with IC50 of 5.2 and 2.9 nM for PARP-1 and PARP-2, respectively; displays no activity against SIRT2 and selective biochemical profile in a panel of 74 receptor-binding assays; strongly potentiates temozolomide in the B16F10 s.c. murine melanoma model, also potentiates temozolomide, platinums, cyclophosphamide, and radiation in syngeneic and xenograft tumor models. Breast Cancer Phase 3 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ABT-888 dihydrochloride | ABT888 dihydrochloride | ABT 888 dihydrochloride
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    PARP1|PARP2
  • Research Area
    Cancer
  • Indication
    Breast Cancer

Chemical Information

  • CAS Number
    912445-05-7
  • Formula Weight
    317.2142
  • Molecular Formula
    C13H18Cl2N4O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 3.2 mg/mL
  • SMILES
    C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N.Cl.Cl
  • Chemical Name
    1H-Benzimidazole-7-carboxamide, 2-[(2R)-2-methyl-2-pyrrolidinyl]-, hydrochloride (1:2)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Donawho CK, et al. Clin Cancer Res. 2007 May 1;13(9):2728-37. 2. Albert JM, et al. Clin Cancer Res. 2007 May 15;13(10):3033-42. 3. Liu X, et al. Mol Cancer Res. 2008 Oct;6(10):1621-9. 4. Palma JP, et al. Anticancer Res. 2008 Sep-Oct;28(5A):2625-35.
molnova catalog
related products
  • Fluzoparib

    fluzoparib is a novel, potent, and orally available inhibitor of PARP, potentially for the treatment of solid tumours.Fluzoparib potently inhibited PARP1 enzyme activity and induced DNA double-strand breaks, G2 /M arrest, and apoptosis in homologous recombination repair (HR)-deficient cells.?

  • OUL35

    OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.

  • PARP-1-IN-2

    PARP-1-IN-2 is a potent PARP1 inhibitor that crosses the blood-brain barrier (IC50: 149 nM).PARP-1-IN-2 showed significant antiproliferative activity against the human lung adenocarcinoma epithelial cell line A549 in cellular assays.